To increase neurologist awareness and inform future efficiency efforts, we identified all neurology-related Choosing Wisely items. Items were categorized by neurologic specialty, disease/symptom, and test/treatment. Of 370 items provided by 65 medical societies, 74 (20%) items were relevant to neurologists. Twelve were duplicated by multiple societies. Items pertaining to 10 neurologic subspecialties were identified, but none for movement disorders and neuromuscular disease. While many recommendations question the use of imaging, few address other high-cost neurologic tests such as EMG/nerve conduction studies and EEG. A rapidly growing number of neurology-related Choosing Wisely recommendations exist including areas of consensus and areas with few recommendations despite high costs. Consensus items should be prioritized for nearterm interventions, while areas with few recommendations represent opportunities for future research.
3. Do not use opioid or butalbital treatment for migraine except as a last resort. 4 . Do not prescribe interferon-b or glatiramer acetate to patients with disability from progressive, nonrelapsing forms of multiple sclerosis. 5 . Do not recommend carotid endarterectomy for asymptomatic carotid stenosis unless the complication rate is low (,3%).
Imaging for low back pain 6. Do not do imaging for low back pain within the first 6 weeks, unless red flags are present. 7 . Do not obtain imaging (plain radiographs, MRI, CT, or other advanced imaging) of the spine in patients with nonspecific acute low back pain and without red flags. 8 . Do not obtain imaging studies in patients with nonspecific low back pain. 9 . Do not recommend advanced imaging (e.g., MRI) of the spine within the first 6 weeks in patients with nonspecific acute low back pain in the absence of red flags. 10 . Avoid imaging studies (MRI, CT, or X-rays) for acute low back pain without specific indications. 11 . Do not initially obtain X-rays for injured workers with acute nonspecific low back pain.
12. Do not order an imaging study for back pain without performing a thorough physical examination.
13. Avoid lumbar spine imaging in the emergency department for adults with nontraumatic back pain unless the patient has severe or progressive neurologic deficits or is suspected of having a serious underlying condition (such as vertebral infection, cauda equine syndrome, or cancer with bony metastasis).
CT scans for minor head injury/syncope 18. In the evaluation of simple syncope and a normal neurologic examination, do not obtain brain imaging studies (CT or MRI).
Medications for insomnia
19. Do not use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation, or delirium.
20. Avoid use of hypnotics as primary therapy for chronic insomnia in adults; instead offer cognitive-behavioral therapy, and reserve medication for adjunctive treatment when necessary.
21. Do not prescribe medication to treat childhood insomnia, which usually arises from parent-child interactions and responds to behavioral intervention.
Do not routinely prescribe antipsychotic medications as a first-line intervention for insomnia in adults.
Antipsychotics for behavioral symptoms 23. Do not use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia.
24. Do not prescribe antipsychotic medications for behavioral and psychological symptoms of dementia in individuals with dementia without an assessment for an underlying cause of the behavior.
25. Do not use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia.
Feeding tubes in dementia 26. Do not recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral assisted feeding.
27. Do not recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral assisted feeding.
28. Do not insert percutaneous feeding tubes in individuals with advanced dementia; instead, offer oral assisted feedings. Imaging 46. Do not routinely screen for brain aneurysms in asymptomatic patients without a family or personal history of brain aneurysms, subarachnoid hemorrhage, or genetic disorders that may predispose to aneurysm formation.
Continued
47. Neuroimaging (CT, MRI) is not necessary in a child with simple febrile seizure.
Do not routinely order imaging for all patients with double vision.
49. Avoid ordering a brain CT or brain MRI to evaluate an acute concussion unless there are progressive neurologic symptoms, focal neurologic findings on examination, or there is concern for a skull fracture.
50. Do not order CT scan of the head/brain for sudden hearing loss.
51. Do not perform CT imaging for headache when MRI is available, except in emergency settings.
52. Do not order low back X-rays as part of a routine preplacement medical examination.
53. Do not use PET imaging in the evaluation of patients with dementia unless the patient has been assessed by a specialist in this field.
54. Avoid transesophageal echocardiography to detect cardiac sources of embolization if a source has been identified and patient management will not change.
publish a list to date, many other societies have made recommendations that address clinical care provided by neurologists. Specialty societies are developing these lists at a rapid pace, with 9 societies contributing 45 items between September 2014 and February 2015.
The aim of this study was to identify all Choosing Wisely items pertinent to neurologists, make them easily accessible, and categorize them by neurologic subspecialty, disease/symptom, and test/treatment. Furthermore, we sought to highlight areas where recommendations are lacking and where consensus already exists to inform future development of top 5 lists.
METHODS

Two board-certified neurologists (BCC, LES) independently identified all Choosing
Wisely items relevant to neurologists using the master list provided on the Choosing Wisely Web site (downloaded on February 19, 2015, from http://www.choosingwisely. org/doctor-patient-lists/). Disagreements were resolved via adjudication with a third neurologist (L.B.D.L.). Three neurologists (BCC, LES, LBD) then categorized the 68. Do not order continuous telemetry monitoring outside of the intensive care unit without using a protocol that governs continuation.
69. Do not routinely add adjuvant whole-brain radiation therapy to stereotactic radiosurgery for limited brain metastases.
70. Do not use polysomnography to diagnose restless legs syndrome, except rarely when the clinical history is ambiguous and documentation of periodic leg movements is necessary. 74. Do not routinely order low-osmolar or iso-osmolar radiocontrast media or pretreat with corticosteroids and antihistamines for patients with a history of seafood allergy who require radiocontrast media.
Abbreviation: ANA 5 antinuclear antibodies.
neurology-related items by neurologic specialty, disease/symptom, and test/treatment using group consensus. Items that were duplicated by multiple societies were also identified.
RESULTS
The Choosing Wisely master list contained a total of 370 items from 65 specialty societies. Of these 370 items, 74 recommendations (20%) from 30 different specialty societies were determined to address clinical activities performed by neurologists (table) . 2 Of the 74 neurology-related items, 5 were proposed by the AAN. Five other specialty societies also issued 5 neurology-related items including the American Academy of Sleep Medicine, American Academy of Physical Medicine and Rehabilitation, American Academy of Neurological Surgeons, American Geriatrics Society, and American Headache Society.
The neurologic subspecialties with the most items were general neurology (n 5 33), followed by cognitive (n 5 10), stroke (n 5 10), and headache (n 5 8) disciplines (figure 1). Of note, no items were identified in the fields of movement disorders or neuromuscular disease, and only one item each pertaining to epilepsy and multiple sclerosis (MS). The neurologic diseases/ symptoms with the most items were low back pain (n 5 15), dementia/delirium (n 5 10), headache (n 5 8), concussion/traumatic brain injury (n 5 6), and stroke (n 5 5) ( figure 2A) .
The tests/treatments with the most items were imaging (n 5 28), opioids (n 5 6), antipsychotics (n 5 4), and polysomnogram (PSG) (n 5 4) ( figure 2B ). Only one item was found for EEG, antiepileptic drugs (AEDs), and MS medications. The only EEG item was for patients with headache, and the only AED recommendation was to question prophylactic use in Figure 1 Choosing Wisely items by neurologic specialty
The number of Choosing Wisely items categorized by neurologic specialty. N-Oph 5 neuro-ophthalmology; N-Oto 5 neuro-otology.
Knowledge of these recommendations is important in delivering efficient neurologic care and should be used to jumpstart patient and physician communication regarding the need for these tests and treatments.
ischemic stroke patients. Only 2 items addressed electrodiagnostic tests (EMG/nerve conduction studies [NCS]) and both addressed their use in patients with spine pain. Topics that were duplicated by multiple societies included recommendations to question imaging in patients with low back pain (n 5 8), CT scans for mild head injury (n 5 4), medications for insomnia (n 5 4), placement of feeding tubes in patients with dementia (n 5 3), antipsychotics for behavioral control in patients with dementia (n 5 3), imaging in patients with uncomplicated or migraine headache (n 5 2), opioids for chronic noncancer pain (n 5 2), carotid imaging for asymptomatic patients (n 5 2), EMG/NCS for spine pain (n 5 2), PSG for insomnia (n 5 2), CT scans for syncope (n 5 2), bed rest for low back pain (n 5 2), and autoantibody panels without a positive antinuclear antibody (n 5 2) (table) .
DISCUSSION
While the AAN established one top 5 Choosing Wisely list, 69 additional neurology-relevant recommendations have been proposed by other medical specialty societies. Of all the Choosing Wisely items, 1 in 5 addressed clinical activities performed by neurologists, but only 7% were issued by a neurology society. Knowledge of these recommendations is important in delivering efficient neurologic care and should be used to jumpstart patient and physician communication regarding the need for these tests and treatments.
Interestingly, 12 Choosing Wisely neurology-relevant recommendations have been duplicated by multiple specialty societies. These likely represent a consensus among the medical community that they are commonly ordered medical services of low value. For these consensus recommendations, such as not imaging patients with low back pain, now is the time to concentrate our efforts on interventions designed to reduce these unnecessary tests. Furthermore, future Choosing Wisely recommendations, like the second top 5 list from the AAN, will have to balance the importance of establishing new consensus recommendations with exploring new medical tests and treatments to target.
We also found multiple areas that have not received attention. No current Choosing Wisely items pertain to the neurologic subspecialties of movement disorders and neuromuscular diseases and only one item each pertains to epilepsy and MS. An opportunity exists to identify commonly performed tests and treatments of questionable benefit in these subspecialties. Furthermore, prior research shows that the tests with the highest aggregate costs in outpatient neurology are MRI, EMG/NCS, and EEG. 3 While many Choosing Wisely recommendations call into question MRI use in several common clinical scenarios, such as low back pain and headache, only one item pertaining to EEG and only one unique item involving EMG/NCS were identified. Given that these tests have large costs associated with them, EEG and EMG/ NCS should be the focus of future efforts to identify neurology efficiency targets. In the United States, we currently spend more money on neurologist-ordered MRIs than on reimbursement for neurology visits. 3 Moreover, neurologist-ordered EMG/NCS and EEGs combined account for more than half of the money spent on neurology visit reimbursement. By continuing to rely on expensive tests, our specialty runs the risk of devaluing our most important value to patients and the medical community, namely seeing patients in clinic and managing their care. Providing efficient neurologic care is likely to be particularly relevant Neuroimaging for headache and low back pain are ideal intervention candidates as multiple societies and guidelines have recommended against their use.
to neurologist compensation as health care reimbursement changes from volume to valuebased systems such as accountable care organizations and medical homes.
It is unlikely that the Choosing Wisely lists will meaningfully affect care without additional dissemination and implementation interventions. Interventions could focus on patients, providers, payers, or a combination; however, specific interventions known to reduce overutilization are limited and should be a focus of future research efforts. Prioritizing which Choosing Wisely items to intervene upon requires consideration of cost. 4 Few data exist to give precise cost estimates for these services in the clinical contexts where their value is questioned. Recently, we estimated that approximately $1 billion per year is spent on neuroimaging for outpatients for headache in the United States. 5, 6 A separate group found similar neuroimaging utilization in headaches. 7 Likewise, high and rising neuroimaging utilization has been reported for patients with low back pain with high resulting costs. 8, 9 Neuroimaging for headache and low back pain are ideal intervention candidates as multiple societies and guidelines have recommended against their use and the costs of guideline discordant care are known to be high. 10, 11 Future studies are needed to probe the costs of the other 64 items, and cost estimates should be provided with all future Choosing Wisely items. With an ever-growing number of specialty societies developing Top 5 lists, finding neurology-relevant items is becoming increasingly challenging. We plan to add these 74 items categorized by neurologic subspecialty, disease/symptom, and test/treatment to the AAN Web site (https://www.aan.com/practice/choosing-wisely/), and update it annually. Neurologists from all subspecialties will be able to quickly review the items most pertinent to their patients and practice. While 74 neurology-related Choosing Wisely items is a great start, future efforts should focus on identifying new targets and designing interventions to reduce utilization of currently identified tests and treatments. author honoraria from Elsevier Inc., and funding for travel from the AAN; receives publishing royalties for Clinical Neurophysiology of the Vestibular System, 4th edition (Oxford University Press, 2011); serves as a consultant for AAN, University of California San Francisco (including work on a project funded by AstraZeneca), and Best Doctors, Inc.; has received a loan repayment award from NIH and speaker honoraria from AAN and University of Southern California; receives research support from NIH/ NIDCD and AHRQ; and has reviewed records in medico-legal cases. J.F. Burke has received honoraria from the AAN for contributing to the Continuum series; has received compensation from AstraZeneca for his role as an adjudicator in the SOCRATES trial; has received research support from NIH; and has reviewed case materials in a medical malpractice defense case. L.E. Skolarus has received hotel accommodations from American Neurological Association and the AAN and funding for travel from the Association of University Professors of Neurology and receives research support from NIH/National Institute of Neurological Disorders and Stroke, Blue Cross Blue Shield of Michigan Foundation, and institutional support from the University of Michigan for stroke-related research. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
